THE PREVENTION AND TREATMENT OF ANAPLASMOSIS
dc.contributor.author | Miller, James G. | en_US |
dc.date.accessioned | 2010-06-01T22:46:24Z | |
dc.date.available | 2010-06-01T22:46:24Z | |
dc.date.issued | 1956-07 | en_US |
dc.identifier.citation | Miller, James G. (1956). "THE PREVENTION AND TREATMENT OF ANAPLASMOSIS." Annals of the New York Academy of Sciences 64(2 Some Protozoan Diseases of Man and Animals: Anaplasmosis, Babesiosis, and Toxoplasmosis ): 49-55. <http://hdl.handle.net/2027.42/75739> | en_US |
dc.identifier.issn | 0077-8923 | en_US |
dc.identifier.issn | 1749-6632 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75739 | |
dc.format.extent | 372613 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1956 The New York Academy of Sciences | en_US |
dc.title | THE PREVENTION AND TREATMENT OF ANAPLASMOSIS | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Science (General) | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan, Ann Arbor, Mich. | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75739/1/j.1749-6632.1956.tb36606.x.pdf | |
dc.identifier.doi | 10.1111/j.1749-6632.1956.tb36606.x | en_US |
dc.identifier.source | Annals of the New York Academy of Sciences | en_US |
dc.identifier.citedreference | Piercy, P. L. 1950. Personal communication. | en_US |
dc.identifier.citedreference | Lotze, J. C. 1947. Variables and constants in experimental bovine anaplasmosis and their relationship to chemotherapy. Am. J. Vet. Research 8 ( 28 ): 267 – 274. | en_US |
dc.identifier.citedreference | Miller, J. G., H. E. Levy, B. J. Torbert & W. T. Oglesby. 1952. A method of screening drugs to be used in the treatment of anaplasmosis—results of testing with Aureomycin and Terramycin. Proc. Am. Vet. Med. Assoc. 89th. Ann. Meet.: 160 – 167. | en_US |
dc.identifier.citedreference | Miller, J. G., H. E. Levy & W. T. Oglesby. 1953. A report of the screening of aralen dihydrochloride for activity against Anaplasma marginale. Am. J. Vet. Research. 14 ( 53 ): 517 – 519. | en_US |
dc.identifier.citedreference | Splitter, E. J. 1949. Anaplasmosis treatment with paludrine. J. Am. Vet. Med. Assoc. 114: 224 – 225. | en_US |
dc.identifier.citedreference | Miller, J. G. 1952. Unpublished data. | en_US |
dc.identifier.citedreference | Pearson, C. C. & W. E. Brock. 1953. Further studies on the use of Aureomycin in anaplasmosis carrier infection. North Am. Veterinarian. 34 ( 6 ): 408 – 412. | en_US |
dc.identifier.citedreference | Foote, L. E. & M. Wulf. 1952. Anaplasmosis carrier infection destroyed with Aureomycin. North Am. Veterinarian. 33 ( 6 ): 406 – 408. | en_US |
dc.identifier.citedreference | Foote, L. E., H. Farley & B. Gallagher. 1951. The use of Aureomycin in anaplasmosis. North Am. Veterinarian. 32 ( 8 ): 547 – 549. | en_US |
dc.identifier.citedreference | Splitter, E. J. & J. G. Miller. 1953. The apparent eradication of the anaplasmosis carrier state with antibiotics. Vet. Med. 48 ( 12 ): 486 – 488. | en_US |
dc.identifier.citedreference | Miller, J. G., H. E. Levy, B. J. Torbert & W. T. Oglesby. 1953. The treatment of anaplasmosis in Louisiana with Aureomycin and Terramycin. J. Am. Vet. Med. Assoc. 122 ( 914 ): 390 – 392. | en_US |
dc.identifier.citedreference | Smith, H. C., & D. E. Howell. 1945. Hemoglobin tests on 175 cases of anaplasmosis. Vet. Med. 40: 272 – 273. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.